Ueda R - Search Results

1

Volumetric measurement of paranasal sinuses and its clinical significance in pituitary neuroendocrine tumors operated using an endoscopic endonasal approach.

Nakaya M, Tamura R, Takahara K, Senuma T, Yoshida K, Kitamura Y, Ueda R, Toda M. Nakaya M, et al. Among authors: ueda r. Front Neurol. 2023 Mar 30;14:1162733. doi: 10.3389/fneur.2023.1162733. eCollection 2023. Front Neurol. 2023. PMID: 37064182 Free PMC article.

2

Identification of a human glioma antigen, SOX6, recognized by patients' sera.

Ueda R, Iizuka Y, Yoshida K, Kawase T, Kawakami Y, Toda M. Ueda R, et al. Oncogene. 2004 Feb 19;23(7):1420-7. doi: 10.1038/sj.onc.1207252. Oncogene. 2004. PMID: 14691456

3

Expression of a transcriptional factor, SOX6, in human gliomas.

Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M. Ueda R, et al. Brain Tumor Pathol. 2004;21(1):35-8. doi: 10.1007/BF02482175. Brain Tumor Pathol. 2004. PMID: 15696967

4

Immunohistochemical analysis of SOX6 expression in human brain tumors.

Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M. Ueda R, et al. Brain Tumor Pathol. 2004;21(3):117-20. doi: 10.1007/BF02482186. Brain Tumor Pathol. 2004. PMID: 15696972

5

Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.

Ueda R, Yoshida K, Kawase T, Kawakami Y, Toda M. Ueda R, et al. Int J Cancer. 2007 Apr 15;120(8):1704-11. doi: 10.1002/ijc.22472. Int J Cancer. 2007. PMID: 17230535

6

Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6.

Ueda R, Kinoshita E, Ito R, Kawase T, Kawakami Y, Toda M. Ueda R, et al. Int J Cancer. 2008 May 15;122(10):2274-9. doi: 10.1002/ijc.23366. Int J Cancer. 2008. PMID: 18224680

7

Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.

Ueda R, Ohkusu-Tsukada K, Fusaki N, Soeda A, Kawase T, Kawakami Y, Toda M. Ueda R, et al. Int J Cancer. 2010 Feb 15;126(4):919-29. doi: 10.1002/ijc.24851. Int J Cancer. 2010. PMID: 19728337

8

A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma.

Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. Shibao S, et al. Among authors: ueda r. Oncotarget. 2018 Apr 20;9(30):21569-21579. doi: 10.18632/oncotarget.25131. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765561 Free PMC article.

9

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma.

Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. Kikuchi R, et al. Among authors: ueda r. J Clin Med. 2019 Feb 20;8(2):263. doi: 10.3390/jcm8020263. J Clin Med. 2019. PMID: 30791546 Free PMC article.

10

A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.

Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M. Tamura R, et al. Among authors: ueda r. Nat Commun. 2019 Dec 17;10(1):5758. doi: 10.1038/s41467-019-13640-1. Nat Commun. 2019. PMID: 31848332 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,128 results

Search Page

Filters